Back to results
US 8,598,186 B2Granted
CDK inhibitors
AssigneeG1 Therapeutics, Inc.
InventorsFrancis X. Tavares, Jay C. Strum
Life of this patent
Estimating the term…
Abstract
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Claims24
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
A compound of the structure:
- wherein R2 is -(alkylene)m-heterocyclo or -(alkylene)m-heteroaryl,
- R is hydrogen, and
- X is independently CH or N.
A compound of the structure:
- wherein R2 is -(alkylene)m-heterocyclo or -(alkylene)m-heteroaryl,
- R is hydrogen, and
- X is independently CH or N.
Dependencies are inferred from the claim text.